A functional cure is a medical treatment that durably suppresses a disease after a single dose or a limited course, so that the patient no longer needs continuing therapy. The cause of the disease, such as a virus or a faulty gene, may still be present in the body, which distinguishes a functional cure from complete eradication. The term is used for chronic conditions such as HIV, hepatitis B, type 1 diabetes and inherited blood disorders, and is closely tied to gene editing and cell therapies.
In biotechnology investing the idea matters because it changes the economics of a drug. A chronic therapy earns revenue for as long as the patient takes it. A one-time treatment is paid for once, usually at a very high price, and each treated patient leaves the market. Durability can be proven only by long follow-up. The theme sits beside genomics and longevity in thematic investing.